How to Document CPAP Intolerance So Your Sleep Service Will Consider an Alternative
Documenting CPAP intolerance the way European sleep services actually read it
A four-week usage curve, a dated side-effect log and the right national form decide whether your sleep service signs off a switch.
What documenting CPAP intolerance actually means
Documenting CPAP intolerance means producing three artefacts: a four-week telemonitoring usage curve, a dated side-effect log with severity scores, and a written record of every mask and setting you already tried. No European sleep service changes therapy because a patient says the mask is unbearable. The switch is authorised by a specialist's documented indication plus a national form, and your file is the evidence it stands on.
Bring feelings and the appointment ends in another cycle. Bring dates, hours and numbers and it changes shape. Start by separating the side effects that can still be fixed from the ones that will not resolve, because your pneumologue, Schlafmediziner or sleep physician asks that question in the first two minutes.
- Three artefacts carry the case: a 28-day usage curve, a dated symptom log, a mask-trial record.
- The European gate is a physician's indication plus a statutory form, never a patient affidavit.
Where the standard advice on documenting CPAP intolerance breaks down
Almost every page ranking for this question was written for the American system. Two flaws follow, and both cost European patients a cycle.
The first is the intolerance affidavit. Search the phrase and you find downloadable sworn statements declaring an inability to use the device. That artefact has no field in any European health system. Your signature is not the trigger anywhere.
The second is treating usage data as a test instead of as evidence. Compliance guides teach you to read your hours, residual AHI and leak rate as a score to satisfy. Those same numbers are the strongest argument for leaving it, and almost nobody says so. Before building the file, exhaust the adjustments a clinic expects you to have tried: humidification, expiratory pressure relief (EPR), a different mask type, a slower ramp. Each one you skip becomes a reason to send you away.
- A patient-signed intolerance affidavit is a US artefact with no EU equivalent.
- Log every fix you attempted, with dates, or it counts as never attempted.
CPAP intolerance is not CPAP ineffectiveness
Intolerance means you cannot wear it. Ineffectiveness means you wear it and it fails to control your apnoea-hypopnoea index (AHI, written IAH in France). Sleep services route these two files to different places, so mislabelling yours stalls a switch request.
| What your data shows | How the service reads it | Where it routes you |
|---|---|---|
| 90 minutes of use per night, residual AHI 2 | Intolerance: the pressure works, the interface does not | Alternative device, usually a mandibular advancement splint |
| 7 hours of use, residual AHI 18 | Ineffectiveness: worn well, controlled badly | CPAP titration and re-titration, APAP or bilevel (BiPAP), leak correction |
| 7 hours of use, residual AHI 3, still sleepy in the day | Treated but symptomatic | Repeat Epworth Sleepiness Scale (ESS), search for a second sleep disorder |
| Mask abandoned in week one, no trials recorded | Untried options remain | Back to the provider for a mask change and another cycle |
Long nightly hours plus a high residual AHI invite a refusal: the obvious answer is a pressure change you have not tried.
- Low usage plus low residual AHI is the pattern that justifies a device change.
- High residual AHI with good usage is a titration problem, not an intolerance case.
The first four weeks decide the case
The shape of month one predicts almost everything. A 2025 cohort published in Thorax (BMJ), run across Imperial College London, King's College London, NHS trusts and Istituto Auxologico Italiano, found 62% of patients non-adherent by month 3, and 98% of those were already non-adherent at month 1. Six usage patterns were identifiable in that first month.
So a four-week curve captured early argues better than a six-month average. The curve shows the clinician the night your usage collapsed, and whether it recovered.
Stopping is common, and your service knows it. A French five-year cohort in Sleep Medicine (2025) recorded termination rates of 17.1% at one year, 26.8% at three years and 28.9% at five. Pooled across twenty years of collected data, the Journal of Otolaryngology - Head & Neck Surgery (2016) put overall non-adherence at 34.1%, with behavioural intervention improving usage by about an hour a night.
- Capture a 28-day curve as soon as trouble starts, not after six months of averages.
- Coaching adds roughly an hour a night on average, which is often not enough.
Getting your usage data when the machine is not yours
In France, Germany and much of the EU your telemonitoring stream sits with a homecare provider, the prestataire de santé à domicile, not with the hospital sleep unit. That company is the data controller. GDPR Article 15 gives you confirmation that personal data concerning you is being processed and access to it, and Article 15(3) requires the controller to provide a copy of the data undergoing processing, with a fee allowed only for further copies.
Name the article and specify the fields. Vague requests come back as a one-page summary.
Remote monitoring runs on the manufacturer's clinician portal, mirrored to a patient app. The patient view shows a simplified score; the clinician view holds the detail, and the observance record used for reimbursement, the télésuivi data, sits there too.
- The homecare provider, not the hospital, normally holds your raw usage data.
- GDPR Article 15 gives you a right of access and a free first copy.
Which side effects actually document CPAP intolerance
Complaints are not equal in a file. The French InterfaceVent real-life study of 1,484 long-term CPAP users (Respiratory Research, 2021) found patient-reported leaks affected 75.4% of responders, the most prevalent side effects measured, while non-adherence in that cohort was 8.6%. A problem three-quarters of users report does not distinguish your case at all.
Gradable, dateable injury does. In the same 1,484-patient cohort (Respiratory Research, 2024), patient-reported mask injury scoring 5 or more on a visual analogue scale was significantly more common in women than men, 9.6% versus 5.3% (p = 0.021). Mask-related skin injury has a location, a date, a score and a photograph. A leak has none of that.
Rank your log accordingly. Skin injury and pressure marks first, with photographs. Then aerophagia, the swallowed air that distends your stomach, with the nights it woke you. Then claustrophobia, counted as nights the mask came off before 3 a.m. Then xerostomia, rhinitis and nasal congestion, each with what you tried against it.
- "My mask leaks" is the least differentiating sentence you can bring.
- An Epworth score that has not improved on therapy is a standardised, repeatable marker.
The gate in your own country
France, the UK and Germany all recognise documented non-tolerance, each through a different instrument.
| Country | The instrument | What it needs | The clock |
|---|---|---|---|
| France | Accord préalable via the prescription form Réf. 634 Cnam, in force since 15 June 2018 | A physician's indication; ameli lists "échec ou intolérance d'un traitement par pression positive continue" as an OAM indication, for IAH 15-30 | Initial PPC prescription valid four months; observance calculated over 28 days; annual renewal |
| United Kingdom | NICE NG202: consider a splint "if CPAP is not tolerated or declined" | Documented non-tolerance, age 18 or over, and "optimal dental and periodontal health" | Clinic review cycles; the dental assessment comes before the decision |
| Germany | MVV-RL Anlage I Nummer 36, after the G-BA decision of 20 November 2020, in force 24 February 2021 | A vertragsärztliche Indikationsstellung: the physician indicates, the dentist supplies the Unterkieferprotrusionsschiene | Statutory cover for "leichter bis mittelgradiger" OSA only; severe OSA sits outside this route |
Two French details matter. Ameli's physician guidance states that PPC must be used at least three hours each night, and that cover for an orthèse d'avancée mandibulaire (OAM) excludes cover for PPC, so it is one or the other. OAM renewal at two years also requires improved symptoms and at least a 50% fall in the apnoea-hypopnoea index. Read how the French reimbursement route is structured before your appointment.
The UK precondition catches people out. Because NG202 conditions the splint on dental and periodontal health, that assessment is part of the CPAP intolerance file. Arrive without it and you lose a cycle.
- France gates on a prior-authorisation form, the UK on a NICE conditional plus dental health, Germany on a physician's statutory indication.
- Approval and funding are separate questions in the UK.
A four-week protocol for documenting CPAP intolerance
1Send the data request on day one
Email the homecare provider citing GDPR Article 15 and list the fields above. Providers take weeks, so day one matters.
2Run one controlled change per week
Week one, humidification and heated tubing. Week two, a different mask category. Week three, pressure relief or a mode change if your team allows it. One variable at a time, each with a date and an outcome.
3Keep the log nightly, not weekly
Date, hours worn, the time the mask came off, the symptom, severity from 0 to 10. Retrospective logs read as reconstruction.
4Book the dental assessment now
If a splint is your likely destination, get dental and periodontal health confirmed in writing during the documentation window.
5Write one page on top
Two sentences naming the category, intolerance or ineffectiveness. A table of what you tried and when. Your Epworth score then and now. One sentence asking for the next therapy, named correctly for your country.
- Four weeks builds a decisive file if the data request goes out immediately.
- The covering page does the job of the affidavit that Europe does not use.
What happens at the review appointment
The consultation is short and mostly happens on screen. Your clinician opens the telemonitoring portal, reads the usage bars, the residual AHI trend and the leak rate, then asks whether you tried a different mask. That question is a gate. If nothing in the record shows the trial, it counts as untried and you go back to the provider.
- The printed 28-day usage curve, with the collapse visible.
- The nightly side-effect log, with scores and dates.
- The mask and settings trial record, one line each.
- Your Epworth Sleepiness Scale score at diagnosis and today.
- The dental confirmation, if a splint is the target.
- Your original polysomnography, polygraphie ventilatoire or home sleep apnoea test report.
Ask explicitly that the decision and its reason go into your record. A verbal agreement does not survive a change of clinician.
- The portal is opened in front of you, so the data speaks before you do.
- An unrecorded mask trial is treated as no trial.
Write the file so it protects your driving licence
Stopping treatment and switching treatment feel identical to you and read very differently to a licensing authority. Commission Directive 2014/85/EU amended Annex III of the driving licence directive so that licences "may be issued to applicants or drivers with moderate or severe obstructive sleep apnoea syndrome who show adequate control of their condition and compliance with appropriate treatment". Member States were required to transpose it by 31 December 2015.
Your file has two readers. Word it as a supervised transition under specialist follow-up, naming the interim arrangement and the review date, not as a decision to stop. Tell your clinician you drive.
- Directive 2014/85/EU ties the licence to control of the condition and compliance with treatment.
- Write the file as a supervised switch with a named review date, never as abandonment.
What a sleep service can realistically switch you to
The mandibular advancement splint is the default European alternative: MAS in the UK, OAM in France, UPS in Germany, dispositivo de avance mandibular (DAM) in Spain. A 2026 trial from the University of Antwerp, published in the American Journal of Respiratory and Critical Care Medicine, found these devices non-inferior to CPAP on mean disease alleviation (MDA), 49.9% versus 49.1% (p = 0.4), with higher nightly adherence at 6.7 hours and 51% of the 94 patients preferring the device against 42% for CPAP.
The multicentre CHOICE trial in the European Respiratory Journal (2025) pointed the same way: mean objective adherence over one month of 6.0 hours a night with a splint against 5.3 with CPAP, and 55% of participants, 35 of 64, chose to alternate between the therapies.
Services also consider positional therapy where your study shows a supine-dominant pattern, hypoglossal nerve stimulation in specialist centres, upper-airway surgery after drug-induced sleep endoscopy (DISE), and weight management.
Where a nasal stent fits while the file is being built
Authorisation takes weeks to months, and in that window you are untreated. Back2Sleep is a CE-certified Class I soft silicone intranasal stent from a French company in Paris that keeps the nasal airway open during sleep. No prescription, no electricity, no tubing, no noise; the starter kit holds four sizes at around 39 euros, ships across Europe and carries a 30-day money-back guarantee. It is a reasonable stopgap for snoring and the mild-to-moderate component (AHI 5-30) while the file is assembled, and a possible destination if your study lands there.
Three limits belong on a page about documenting honestly. Severe OSA is out: France's OAM cover is aimed at an IAH between 15 and 30, and the German statutory route stops at "leichter bis mittelgradiger" disease. No EU reimbursement pathway recognises a nasal stent as a funded alternative, so it does not replace the file you are building. The class evidence is thin. A Swiss evaluation of a nasopharyngeal stent (Journal of International Medical Research, 2022) enrolled 122 patients and excluded 21, fourteen of them for stent intolerance, concluding the device "is a viable tool to reduce palatal obstructions, although it is not readily tolerated".
- Splint evidence is strong: non-inferior on mean disease alleviation, better adherence in the 2025 and 2026 trials.
- A nasal stent is an interim or mild-to-moderate option, never a severe-OSA therapy and never a reimbursed one.
What Back2Sleep Users Say
Frequently Asked Questions
How long do I have to use CPAP before my doctor will consider an alternative?
There is no single European rule. In France an initial PPC prescription runs four months, with observance calculated over 28 days and renewal each year, so a switch request usually lands at a review point. A documented four-week usage curve and recorded mask trials matter more than total elapsed months.
How do I get my CPAP compliance report if the machine belongs to the provider?
Ask the homecare provider in writing, citing GDPR Article 15. It is normally the data controller for your telemonitoring stream, and Article 15(3) requires it to give you a copy of the data being processed, free for the first copy. Name the fields you want: nightly hours, residual AHI, leak rate and pressures.
Can I switch from PPC to an orthèse d'avancée mandibulaire and stay reimbursed in France?
Ameli lists failure or intolerance of continuous positive airway pressure as an indication for an OAM, aimed at an IAH between 15 and 30, and the request goes through the accord préalable form Réf. 634 Cnam. Cover for an OAM excludes cover for PPC, so it is one therapy or the other.
Do I have to tell my licensing authority if I stop using my CPAP?
Raise it with your clinician first. Commission Directive 2014/85/EU allows licences for drivers with moderate or severe obstructive sleep apnoea who show adequate control and compliance with appropriate treatment. A file recording a supervised switch, with an interim plan and a review date, reads very differently from one recording abandonment.
Can I get a mandibular advancement splint on the NHS or do I have to pay?
NICE NG202 says to consider a splint if CPAP is not tolerated or declined, in adults with optimal dental and periodontal health. Access is uneven. The OSA Alliance reports that splints cannot be reliably and equally accessed because NHSE pathways and tariffs are missing, with some areas offering none at all.
Does a home sleep apnoea test count as evidence when I ask to change treatment?
Your original diagnostic study anchors the file, whether it was full polysomnography, respiratory polygraphy or a home sleep apnoea test. It fixes your AHI band, which decides which therapies your system will fund. Bring it alongside the usage curve, because a home test on its own rarely justifies a switch.
What should I bring to my sleep clinic appointment to prove CPAP is not working?
Bring a printed 28-day usage curve, a nightly side-effect log with severity scores and dates, a record of every mask and setting tried, your Epworth score at diagnosis and today, your original sleep study report, and a dental check if a splint is your likely destination.
Ready for quieter nights? Discover the Back2Sleep starter kit and find the right fit for you.
Not sure if you are at risk? Take our sleep risk screening to find out in just a few minutes.
Want to learn how it works? Explore the Back2Sleep nasal stent designed for comfortable, effective relief.